Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Leleu

Showing results (61-70 of 372) with videos related to

Pageof 38
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Front line treatment of elderly multiple myeloma in the era of novel agentsMarie-Dominique Venon, Aldo M Roccaro, Julie Gay, et al.
Expert Opinion on Pharmacotherapy|April 9, 2009
Bortezomib and Waldenstrom's macroglobulinemiaLaurent Pascal, Julie Gay, Christophe Willekens, et al.
Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myelomaOmar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Annals of Hematology|April 21, 2025
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trialsMeletios Dimopoulos, Kazutaka Sunami, Xavier Leleu, et al.
British Journal of Haematology|May 27, 2005
Evaluation and prognostic value of serum osteoprotegerin in multiple myelomaStéphane Depil, Claire Mathiot, Xavier Leleu, et al.
Seminars in Cancer Biology|January 8, 2004
HLA-G and lymphoproliferative disordersLaurence Amiot, Gaëlle Le Friec, Yasmine Sebti, et al.
Haematologica|February 8, 2006
Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survivalIsabelle Vande Broek, Isabelle Van de Broek, Xavier Leleu, et al.
Cancers|November 11, 2022
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in EuropeEvangelos Terpos, Renato Zambello, Xavier Leleu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patientsMaud Brousseau, Xavier Leleu, Jérémie Gerard, et al.
Pageof 38

Showing results (61-70 of 372) with videos related to

Sort By:
Pageof 38
Biologics : Targets & Therapy|August 27, 2009
Front line treatment of elderly multiple myeloma in the era of novel agentsMarie-Dominique Venon, Aldo M Roccaro, Julie Gay, et al.
Expert Opinion on Pharmacotherapy|April 9, 2009
Bortezomib and Waldenstrom's macroglobulinemiaLaurent Pascal, Julie Gay, Christophe Willekens, et al.
Drugs of Today (Barcelona, Spain : 1998)|August 19, 2022
Melphalan flufenamide for relapsed/refractory multiple myelomaOmar Nadeem, Maria-Victoria Mateos, Yvonne A Efebera, et al.
Expert Review of Hematology|December 11, 2012
Immunomodulator drug-based therapy in myeloma and the occurrence of thrombosisEileen M Boyle, Guillemette Fouquet, Salomon Manier, et al.
Annals of Hematology|April 21, 2025
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trialsMeletios Dimopoulos, Kazutaka Sunami, Xavier Leleu, et al.
British Journal of Haematology|May 27, 2005
Evaluation and prognostic value of serum osteoprotegerin in multiple myelomaStéphane Depil, Claire Mathiot, Xavier Leleu, et al.
Seminars in Cancer Biology|January 8, 2004
HLA-G and lymphoproliferative disordersLaurence Amiot, Gaëlle Le Friec, Yasmine Sebti, et al.
Haematologica|February 8, 2006
Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survivalIsabelle Vande Broek, Isabelle Van de Broek, Xavier Leleu, et al.
Cancers|November 11, 2022
Real-World Use and Effectiveness of Carfilzomib Plus Dexamethasone in Relapsed/Refractory Multiple Myeloma in EuropeEvangelos Terpos, Renato Zambello, Xavier Leleu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patientsMaud Brousseau, Xavier Leleu, Jérémie Gerard, et al.
Pageof 38